Bhatia S, Nghiem P, Veeranki SP, Vanegas A, Lachance K, Tachiki L, Chiu K, Boller E, Bharmal M. Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study. J Immunother Cancer. 2022 Aug;10(8):e004904. doi: 10.1136/jitc-2022-004904
Quan M, Cho N, Bushell T, Mak J, Nguyen N, Litwak J, Rockwood N, Nguyen HB. Effectiveness of angiotensin II for catecholamine refractory septic or distributive shock on mortality: a propensity core weighted analysis of real-world experience in the medical ICU. Crit Care Explor. 2022 Jan 18;4(1):e0623. doi: 10.1097/CCE.0000000000000623
Bhatia S, Nghiem P, Veeranki SP, Vanegas A, Lachance K, Tachiki L, Chiu K, Boller E, Bharmal M. Real-world clinical outcomes among patients with advanced Merkel cell carcinoma treated with avelumab in academic medical centers in the United States. Poster presented at the SITC 2021 36th Anniversary Annual Meeting; November 9, 2021. Washington, DC. [abstract] J Immunother Cancer. 2021 Nov; 9(Suppl 2):A658.